You just read:

European Investment Bank (EIB) Extends Financing Agreement to €24 Million Total in Support of BiondVax's Universal Flu Vaccine Ongoing Pivotal Phase 3 Clinical Trial

News provided by

BiondVax Pharmaceuticals Ltd.

Apr 22, 2019, 08:10 ET